Reasons for switching to fingolimod in patients relapsing-remitting multiple sclerosis in France: the ESGILE study. En savoir plus sur Reasons for switching to fingolimod in patients relapsing-remitting multiple sclerosis in France: the ESGILE study.
Expert opinion: Criteria for second-line treatment failure in patients with multiple sclerosis. En savoir plus sur Expert opinion: Criteria for second-line treatment failure in patients with multiple sclerosis.
Cognitive complaint in early Parkinson''s disease: A pilot study. En savoir plus sur Cognitive complaint in early Parkinson''s disease: A pilot study.
Treatment satisfaction and quality of life in patients treated with fingolimod. En savoir plus sur Treatment satisfaction and quality of life in patients treated with fingolimod.